Merck Bovilis® Vista® 5 SQ

Shown to be effective for the vaccination of healthy cattle 3 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 and 2, bovine respiratory syncytial virus (BRSV) and parainfluenza3 virus (PI3). Respiratory and reproductive efficacy and duration of immunity has been demonstrated against disease caused by the BVD Type 1b strain.

Indications

For vaccination of healthy cattle, 3 months of age or older, as an aid in prevention of disease caused by infectious bovine rhinotracheitis virus (IBR), bovine virus diarrhea virus (BVD) (Type 2), and bovine respiratory syncytial virus (BRSV), and as an aid in control of disease caused by bovine virus diarrhea virus (BVD) (Type 1) and parainfluenza₃ virus (PI³). Duration of Immunity (DOI) has been demonstrated to be at least one year for IBR and BVD (Types 1 & 2). In addition, this product is for vaccination of healthy cows and heifers prior to breeding as an aid in reduction of abortion due to IBR and as an aid in prevention of fetal infection, including persistently infected calves caused by BVD (Types 1 & 2). Reproductive Duration of Immunity has been demonstrated to be at least 217 days for IBR and at least 206 days for BVD (Types 1 & 2). Safe for use in pregnant heifers and cows or calves nursing pregnant cows provided the cows and heifers in the herd are vaccinated prior to breeding, within the previous 12 months, with any of the modified-live IBR and BVD containing vaccine(s) in this product line.

Dosage

2 mL administered subcutaneously to healthy cattle 3 months of age or older. Annual revaccination is recommended.

Supplied

For additional information, please see the product label.